BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24485013)

  • 1. Physical activity intensity and health status perception of breast cancer patients undergoing adjuvant chemotherapy.
    Tonosaki A; Ishikawa M
    Eur J Oncol Nurs; 2014 Apr; 18(2):132-9. PubMed ID: 24485013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer.
    Wielgus KK; Berger AM; Hertzog M
    Oncol Nurs Forum; 2009 Jan; 36(1):38-48. PubMed ID: 19136337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Low-Intensity Physical Activity and Moderate- to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial.
    van Waart H; Stuiver MM; van Harten WH; Geleijn E; Kieffer JM; Buffart LM; de Maaker-Berkhof M; Boven E; Schrama J; Geenen MM; Meerum Terwogt JM; van Bochove A; Lustig V; van den Heiligenberg SM; Smorenburg CH; Hellendoorn-van Vreeswijk JA; Sonke GS; Aaronson NK
    J Clin Oncol; 2015 Jun; 33(17):1918-27. PubMed ID: 25918291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study.
    Berger AM; Higginbotham P
    Oncol Nurs Forum; 2000 Oct; 27(9):1443-8. PubMed ID: 11058976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens.
    Berger AM; Lockhart K; Agrawal S
    Oncol Nurs Forum; 2009 Sep; 36(5):563-70. PubMed ID: 19726396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of a study on fatigue in breast cancer patients receiving adjuvant chemotherapy: the first four days after treatment are the worst].
    de Jong N; Kester AD; Schouten HC; Abu-Saad HH; Courtens AM
    Pflege Z; 2007 Nov; 60(11):620-5. PubMed ID: 18062627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of the fatigue dimension "activity level" and the interference of fatigue with daily living activities for patients with breast cancer receiving adjuvant chemotherapy.
    de Jong N; Candel MJ; Schouten HC; Abu-Saad HH; Courtens AM
    Cancer Nurs; 2006; 29(5):E1-13. PubMed ID: 17006105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence, sleep, and fatigue outcomes after adjuvant breast cancer chemotherapy: results of a feasibility intervention study.
    Berger AM; VonEssen S; Kuhn BR; Piper BF; Agrawal S; Lynch JC; Higginbotham P
    Oncol Nurs Forum; 2003; 30(3):513-22. PubMed ID: 12719750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized pilot study with daily walking during adjuvant chemotherapy for patients with breast and colorectal cancer.
    Backman M; Wengström Y; Johansson B; Sköldengen I; Börjesson S; Tärnbro S; Berglund Å
    Acta Oncol; 2014 Apr; 53(4):510-20. PubMed ID: 24460069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective assessment of fatigue and health status in Greek patients with breast cancer undergoing adjuvant radiotherapy.
    Lavdaniti M; Patiraki E; Dafni U; Katapodi M; Papathanasoglou E; Sotiropoulou A
    Oncol Nurs Forum; 2006 May; 33(3):603-10. PubMed ID: 16676016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical activity during and after adjuvant chemotherapy in patients with breast cancer.
    Johnsson A; Johnsson A; Johansson K
    Physiotherapy; 2013 Sep; 99(3):221-7. PubMed ID: 23219630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy.
    Berger AM
    Oncol Nurs Forum; 1998; 25(1):51-62. PubMed ID: 9460773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An explanatory model of fatigue in women receiving adjuvant breast cancer chemotherapy.
    Berger AM; Walker SN
    Nurs Res; 2001; 50(1):42-52. PubMed ID: 19785244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study.
    Kreukels BP; Schagen SB; Ridderinkhof KR; Boogerd W; Hamburger HL; Muller MJ; van Dam FS
    Clin Breast Cancer; 2006 Apr; 7(1):67-78. PubMed ID: 16764746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical activity in women receiving chemotherapy for breast cancer: adherence to a walking intervention.
    Swenson KK; Nissen MJ; Henly SJ
    Oncol Nurs Forum; 2010 May; 37(3):321-30. PubMed ID: 20439216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study.
    Nieboer P; Buijs C; Rodenhuis S; Seynaeve C; Beex LV; van der Wall E; Richel DJ; Nooij MA; Voest EE; Hupperets P; Mulder NH; van der Graaf WT; TenVergert EM; van Tinteren H; de Vries EG
    J Clin Oncol; 2005 Nov; 23(33):8296-304. PubMed ID: 16219926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.
    Hurria A; Brogan K; Panageas KS; Pearce C; Norton L; Jakubowski A; Zauderer M; Howard J; Hudis C
    Breast Cancer Res Treat; 2005 Jul; 92(2):151-6. PubMed ID: 15986124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in functional status and physical and psychological symptoms in women receiving chemotherapy for breast cancer.
    Ogce F; Ozkan S
    Asian Pac J Cancer Prev; 2008; 9(3):449-52. PubMed ID: 18990020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer.
    Yates P; Aranda S; Hargraves M; Mirolo B; Clavarino A; McLachlan S; Skerman H
    J Clin Oncol; 2005 Sep; 23(25):6027-36. PubMed ID: 16135471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.